Pharmacogenomics of Antidepressant Drugs: Focus on Key Findings and Future Directions

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|12|3|141-147

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.12, Iss.3, 2015-03, pp. : 141-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions

By Narasimhan Sneha   Lohoff Falk W  

Pharmacogenomics, Vol. 13, Iss. 4, 2012-03 ,pp. : 441-464

Future Medicine

Access to resources Recommend Favorite

Serotonin-Dopamine Interaction as a Focus of Novel Antidepressant Drugs

By  

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 177-185

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics of antihypertensive drugs: past, present and future

By Johnson Julie A  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 487-491

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of &bgr;β2-agonist: key focus on signaling pathways

By Bhatnagar Pallav   Guleria Randeep   Kukreti Ritushree  

Pharmacogenomics, Vol. 7, Iss. 6, 2006-09 ,pp. : 919-933

Future Medicine

Access to resources Recommend Favorite

From Human Genetics and Genomics to Pharmacogenetics and Pharmacogenomics: Past Lessons, Future Directions

By Nebert Daniel   Zhang Ge   Vesell Elliot  

Drug Metabolism Reviews, Vol. 40, Iss. 2, 2008-04 ,pp. : 187-224

Informa Healthcare

Access to resources Recommend Favorite